PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.71
arrow_upward
+1.12%(+0.030) 1D
$2.75
arrow_upward
+1.36% (+0.037)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.70
High
$2.72
Low
$2.64
Mkt. cap
218.35M
Avg. vol.
747.59K
Volume
947.40K
P/E ratio
11.98
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
Open
$2.70
High
$2.72
Low
$2.64
Mkt. cap
218.35M
Avg. vol.
747.59K
Volume
947.40K
P/E ratio
11.98
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
Foreign Policy Journal
·
30 minutes ago
AST SpaceMobile (NASDAQ: ASTS) Slides 31% On Convertible Raise And Satellite Delays — Analysts Hold Targets
The Motley Fool
·
30 minutes ago
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
Simply Wall Street
·
32 minutes ago
What Do Alphabet (GOOGL) AI Safety Pact And Antitrust Wins Mean Now?
Business Insider
·
13 hours ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com